JPRN-UMIN000034321已完成未知
A retrospective study of interstitial lung disease due to EGFR tyrosine kinase inhibitor and immune checkpoint inhibitor - NEJ040
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 235
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
尚未招募
Unknown
POPLAR studyPulmonary hypertension, Interstitial lung diseaseD006976, D017563JPRN-jRCT1010230018Tsujino Ichizo250
招募中
不适用
An Observational Cohort Study of Interstitial Lung Abnormalities (ILAs) in a Large Japanese Health Screening Population (Kumamoto ILA study in Japan: KILA-J)Progressive fibrosing interstitial lung diseases including idiopathic pulmonary fibrosisJPRN-UMIN000045149Department of Respiratory Medicine Kumamoto University Medical Sciences1,500
已完成
不适用
A cohort study of idiopathic interstitial pneumonia in Shizuoka.JPRN-UMIN000015370Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine200
已完成
不适用
Study of interstitial lung disease in primary antibody deficiencyD83.9J84.8Common variable immunodeficiency, unspecifiedOther specified interstitial pulmonary diseasesDRKS00000799niversitätsklinikum FreiburgCentrum für Chronische Immundefizienz (CCI)150
招募中
不适用
Pulmonary involvement (interstitial lung disease of known etiology) in patients with Seropositive and ACPA positive Rheumatoid Arthritis (RA-ILD I and II)Early detection of lung involvement in RAM05.9M05.1J99.0Seropositive rheumatoid arthritis, unspecifiedRheumatoid lung diseaseDRKS00028871Boehringer Ingelheim Pharma GmbH & Co. KG200